Table 1.
Active Agent | Brand | Manufacturer | Dosage | Delivery Vehicle | Application and Duration (per Manufacturer/Study Design) | Longest Follow-Up Study | Authors | Study Design | Sample Size |
---|---|---|---|---|---|---|---|---|---|
Chlorhexidine | Chlo-Site® | Ghimas Company, Italy | 1.5% CHX | Gel | 1 application 15 days treatment |
6 months | Paolantonio et al. 2009 [41] | Split-mouth | 98 |
Kranti et al. 2010 [42] | Split-mouth | 10 | |||||||
Jain et al. 2013 [43] | Split-mouth | 30 | |||||||
Matesanz et al. 2013 [44] | Parallel | 22 | |||||||
Periochip® | Perio Products Ltd., Jerusalem, Israel | 2.5 mg CHX gluconate | Chip | 1 application 7 days treatment |
9 months | Jeffcoat et al. 1998 [45] | Parallel * | 419 | |
Grisi et al. 2002 [46] | Parallel * | 20 | |||||||
Carvalho et al. 2007 [47] | Split-mouth * | 28 | |||||||
PerioCol®-CG | Eucare Pharmaceuticals Ltd., Chennai, India | 2.5 mg CHX gluconate | Chip | 1 application 7 days treatment |
12 months | Reddy et al. 2016 [48] | Parallel | 48 | |
EC40® | Biodent BV, Nijmegen, The Netherlands | 35% CHX diacetate | Varnish | 1 application 7 days treatment |
9 months | Cosyn et al. 2006 [49] | Parallel | 26 | |
Doxycycline | Atridox® | Atrix Laboratories, Fort Collins, CO, USA | 10% DOXY hyclate | Gel | 1 application 7 days treatment |
36 months | Bogren et al. 2008 [50] | Parallel * | 132 |
Metronidazole | Elyzol® | Dumex, Copenhagen, Denmark | 25% MET benzoate | Gel | 2 applications 7 days treatment |
12 months | Buduneli et al. 2001 [51] | Split-mouth | 18 |
Minocycline | Arestin® | OraPharma, Inc., Warminster, PA, USA | 1 mg MINO hydrochloride | Micro-spheres | 1 application 14 days treatment |
24 months | Cortelli et al. 2008 [52] | Parallel * | 30 |
Killeen et al. 2018 [53] | Parallel * | 55 | |||||||
Dentomycin® | Lederle Dental Division, Gosport, Hampshire, UK | 2% MINO hydrochloride | Ointment | 3–4 applications 14 days treatment |
18 months | Timmerman et al. 1996 [54] | Parallel * | 20 | |
Periocline® | Sunstar Corp., Tokyo, Japan | ||||||||
Tetracycline | Periodontal Plus ABTM | Advanced Biotech Products, Chennai, India | 2 mg TET hydrochloride | 1 application 7 days treatment |
12 months | Reddy et al. 2016 [48] | Parallel | 48 | |
Enamel matrix derivative | Emdogain® | Institute Straumann AG, Basel, Switzerland | 30 mg/mL porcine enamel matrix derivative | Gel | 1 application | 12 months | Mombelli et al. 2005 [55] | Split-mouth | 16 |
Hyaluronic acid | Aftamed® | BioPlax Limited, London, UK | 240 mg/100 g sodium hyaluronate | Gel | 1 application | 6 weeks | Omer at el. 2018 [56] | Split-mouth | 33 |
Aminogam® | Errekappa Euroterapici, Spa, Italy | Sodium hyaluronate, amino acids | 1 application | 3 months | Bevilacqua et al. 2012 [57] | Split-mouth * | 11 | ||
Gengigel® | Ricerfarma, Italy | 0.2% and 0.8% Sodium hyaluronate | 1 application | 6 months | Eick et al. 2013 [58] | Parallel * | 42 | ||
Healon GV® | Pharmacia and Upjohn, Uppsala, Sweden. | 14 mg/mL sodium hyaluronate | 3 applications 27 days treatment |
12 months | Engstrüm et al. 2001 [59] | Split-mouth * | 9 | ||
Photosensitiser | EmunDo® | A.R.C. laser GmbH, Germany | Indocyanine green (iodide-free) | Dye Solution | 2–4 applications 14–27 days treatment |
3 months | Birang et al. 2015 [60] | Split-mouth | 20 |
Monzavi et al. 2016 [61] | Split-mouth * | 25 | |||||||
HELBO® | Bredent Medical, Germany | Phenothiazine chloride | 1 application | 12 months | Lulic et al. 2009 [62] | Parallel | 10 | ||
Alwaeli et al. 2015 [63] | Split-mouth * | 21 | |||||||
Petelin et al. 2015 [64] | Parallel * | 27 | |||||||
Tabenski et al. 2017 [65] | Parallel | 48 | |||||||
PeriowaveTM | Periowave Dental Technologies Inc, Canada | Methylene blue | 1–3 applications | 6 months | Berakdar et al. 2012 [66] | Split-mouth | 22 | ||
Müller Campanile et al. 2015 [67] | Split-mouth * | 28 | |||||||
Fotosan® | CMS Dental, Copenhagen, Denmark | Toluidine blue/tolonium chloride | 1–3 applications | 6 months | Goh et al. 2017 [68] | Split-mouth | 27 |
CHX: Chlorhexidine; MINO: Minocycline; DOXY: Doxycycline; MET: Metronidazole; TET: Tetracycline. * Repeated application.